Atossa Therapeutics Announces First Quarter 2024 Financial :

Atossa Therapeutics Announces First Quarter 2024 Financial

Atossa Therapeutics Announces First Quarter 2024 Financial

globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

New York , United States , Eric Van Zanten , Tessa Cigler , Eli Lilly , Atossa Therapeutics Inc , Nasdaq , Weill Cornell Breast Center , Exchange Commission , Development Expense , Oestrogen Receptor , Human Epidermal Growth Factor Receptor , Re Evaluating Conditions , Active Surveillance Suitability , Ductal Carcinoma In Situ , Steven Quay , Chief Executive , Three Months Ended March , Three Months Ended , Administrative Expense , Selective Estrogen Receptor Modulator , Private Securities Litigation Reform Act , Nasdaq Stock Market , Annual Reports , Quarterly Reports , Three Months ,